Small Cap Growth Virtual Investor Conference Agenda Announced for October 16th Life Science Investing
PharmaTher Applauds FDA's Commissioner's National Priority Voucher Selection of Ketamine; Company Highlights Potential Ketamine Opportunity, 505 Focus, and Upside from Strategic ANDA Sale Biotech Investing
Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors Biotech Investing
Summit Therapeutics Announces Expansion of Ivonescimab Global Phase III Development Program with HARMONi-GI3 Study in 1L Colorectal Cancer Biotech Investing
